Purchasing by Government
The WSMA will not interfere in the government's prudent purchasing
strategies of prescription drugs for its own specific programs unless the
proposals adversely affect appropriate patient care (Therapeutic
Substitution), interfere with the physician and patient relationship
(Disease Management), or cause undue administrative burden on physician
practices (Rebates with Prior Authorization). (EC 9/00) (Reaffirmed A-23)
Return to the WSMA Policy Compendium index
Abbreviations for House of Delegates report origination:
EC – Executive Committee; BT – Board of Trustees; CPA – Council on
Professional Affairs; JC – Judicial Council; CHS – Community and Health
Services